LUTZ, Fla., Jan. 4, 2018 /PRNewswire/ -- The new SPECTRA™: Indices of Psychopathology offers clinicians a new way to assesspsychopathology in that it measures valuable clinical information on a wide range of psychopathological conditions at three levels of specificity.
The SPECTRA measures 12 clinically important constructs (depression, anxiety, social anxiety,
"Whether addressing discrete disorders or continuous dimensions, psychopathology can demonstrate substantial comorbidity," stated Kristin Greco, MBA, PAR CEO. "Research shows these three higher-order spectra of Internalizing, Externalizing, and Reality-Impairing dimensions can offer clinicians a well-researched model for conceptualizing, measuring, and treating psychiatric concerns."
The SPECTRA takes just 15-20 minutes to administer and can be administered and scored on paper or via the PARiConnect online assessment system. The SPECTRA is useful when evaluating individuals in a variety of clinical settings, such as inpatient and outpatient clinics, hospitals, schools, and forensic settings. It also can help track progress over time if administered repeatedly.
To learn more about the SPECTRA, visit www.parinc.com, or call PAR Customer Support at 1.800.331.8378.
Founded in 1978, PAR is a leading publisher of assessment instruments, software, and other related materials. Over the past three decades, PAR has earned a reputation for providing customers with innovative assessment solutions and unparalleled customer service.
View original content:http://www.prnewswire.com/news-releases/a-new-measure-of-psychopathology-offers-clinicians-advantages-over-similar-tests-300577789.html
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All